Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer

British Journal of Cancer

Volumn 87, Issue 11, 2002, Pages 1275-1280

  Kronqvist, Pauliina ^a   Kuopio, T ^b   Jalava, P ^a   Collan, Y ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

Author keywords

Breast cancer; Grading; Morphometry; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER MORTALITY; CELL DIFFERENTIATION; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MITOSIS RATE; MORPHOMETRICS; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 0037132394     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600617     Document Type: Article

References (56)

1. Aaltomaa S, Lipponen P, Eskelinen M, Alhava E, Syrjänen K (1991) Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer. Eur J Surg 157: 319-332
2. Baak JPA, van Diest PJ, Ariens A (1989) The Multicenter Morphometric Mammary Carcinoma Project (MMMCP). A nation-wide prospective study on reproducibility and prognostic power of routine quantitative assessments in the Netherlands. Path Res Pract 185: 664-670
3. Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359-377
4. Calle R, Viloq JR, Zafrani B, Viehl P, Forquet A (1986) Local control and survival of breast cancer treated by limited surgery followed by radiation. Int J Radiat Oncol Biol Phys 12: 873-878
5. Clayton F (1991) Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor. Cancer 68: 1309-1317
6. Collan Y, Torkkeli T, Kosma V-M, Pesonen E, Kosunen O, Jantunen EI, Mariuzzi GM, Montironi R, Marinelli F, Collina G (1987) Sampling in diagnostic morphometry: The influence of variation sources. Path Res Pract 182: 401-406
7. Collan Y (1989) Grading histological lesions with subjective and quantitative methods. Acta Stereol 8: 109-116
8. Collan Y, Pesonen E (1989) Principles of morphometric grading. Gegeanbaurs Morphol Jahrb 135: 13-17
9. Collan Y, Klemi P, Kallioniemi O, Joensuu H, Nordling S, Eskelinen M (1992) Significance of variation in DNA flow cytometric analyses from paraffin-embedded breast cancers. Evaluation of the grading efficiency of ploidy determination, DNA index, and S-phase fraction. Path Res Pract 88: 581-586
10. Collan YUI, Kuopio T, Baak JPA, Becker R, Bogomoletz WV, Deverell M, van Diest P, van Galen C, Gilchrist K, Javed A, Kosma V-M, Kujari H, Luzi P, Mariuzzi GM, Matze E, Montironi R, Scarpelli M, Sierra D, Sisti S, Toikkanen S, Tosi P, Whimster WF, Wisse E (1996) Standardized mitotic counts in breast cancer. Evaluation of the method. Path Res Pract 192: 931-941
11. Contesso G, Mouriesse H, Friedman S, Genin J, Sarrazin D, Rouesse J (1987) The importance of histologic grade in long-term prognosis of breast cancer; A study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy. J Clin Oncol 5: 1378-1386
12. Contesso G, Jotti GS, Bonadonna G (1989) Tumour grade as a prognostic factor in primary breast cancer. Eur J Cancer Clin Oncol 25: 403-409
13. Cutler SJ, Ederer F (1958) Maximum utilisation of the life table method in analysing survival. J Chron Dis 8: 699-712
14. Davis BW, Gelber RD, Goldhirsch A, Hartmann WH, Locher GW, Reed R, Golough R, Säve-Söderbergh J, Holloway L, Russell I, Rudenstam CM (1986) Prognostic significance of tumour grade in clinical trails of adjuvant therapy for breast cancer with axillary lymph node metastasis. Cancer 58: 2662-2670
15. Elston CW, Gresham GA, Rao GS, Zebro T, Haybittle JL, Houghton J, Kearney G (1982) The cancer research campaign (King's/Cambridge) trial for early breast cancer: Clinico-pathological aspects. Br J Cancer 45: 655-669
16. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer, I. The value of histological grade in breast cancer: Experience from a large study with long term follow-up. Histopathology 19: 403-410
17. Fisher B, Redmond C, Fisher E, Caplan R (1988) Relative worth of oestrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: Findings from national surgical adjuvant breast and bowel project protocol B-06. J Clin Oncol 6: 1076-1087
18. Galen RS, Gambino SR (1975) Beyond normality. In The Predicted Value and Efficiency of Medical Diagnosis pp 49-51 and 115-116 New York: John Wiley and Sons
19. Haapasalo H, Pesonen E, Collan Y (1989) Volume corrected mitotic index (M/V INDEX). The standard of mitotic activity in neoplasms. Pathol Res Pract 185: 551-554
20. Henson DE (1988) The histological grading of neoplasms. Arch Pathol Lab Med 112: 1091-1096
21. Hopton DS, Thorogood J, Clayden AD, MacKinnon D (1989) Histological grading of breast cancer: Significance of grade on recurrence and mortality. Eur J Surg Oncol 15: 25-31
22. Johnson H, Mazood S, Belluco C, Abou-Azama AM, Dee S, Kaha L (1992) Prognostic factors in node-negative breast cancer. Arch Surg 127: 1386-1391
23. Klemi PJ, Joensuu H, Toikkanen S, Tuominen J, Räsänen O, Tyrkkö J, Parvinen I (1992) Aggressiveness of breast cancers found with and without screening. BMJ 304: 467-469
24. Klemi PJ, Toikkanen S, Räsänen O, Parvinen I, Joensuu H (1997) Mammography screening interval and the frequency of interval cancers in population-based screening. Br J Cancer 75: 762-766
25. Kraemer H (1980) Extension of the kappa coefficient. Biometrics 36: 207-216
26. Kronqvist P, Collan Y, Kuopio T, Kujari H (1995) Nuclear morphometry in breast cancer: The influence of sampling rules and freezing of samples. Mod Pathol 8: 187-192
27. Kronqvist P, Kuopio T, Collan Y, Horvath C, Tamm Ü (1997) The reproducibility of nuclear morphometrical measurements in invasive breast carcinoma. Anal Cell Pathol 15: 47-59
28. Kronqvist P, Kuopio T, Collan Y (1998a) Morphometrical grading of invasive ductal breast cancer. I. Thresholds for nuclear grade. Br J Cancer 78: 800-805
29. Kronqvist P, Kuopio T, Collan Y (1998b) Morphometrical grading in breast cancer: Thresholds for mitotic counts. Hum Pathol 29: 1462-1468
30. Kronqvist P, Kuopio T, Collan Y (2000) Quantitative thresholds for mitotic counts in histological grading: Confirmation in non-frozen samples of invasive ductal breast cancer. Ann Diagn Path 4: 65-70
31. Kronqvist P, Kuopio T, Pirvu C, Collan Y (1999) The fraction of fields showing malignant tubuli: The practical estimate of tubular differentiation in breast cancer. Histopathology 35: 401-410
32. Kronqvist P, Kuopio T, Collan Y (2000) Morphometrical grading of breast cancer. Thresholds for tubular differentiation. Br J Cancer 82: 1656-1661
33. Kujari HP, Collan YUI, Atkin NB (1994) Use of the mitotic counts for the prognosis and grading of breast cancer. Method evaluation study. Path Res Pract 190: 593-599
34. Kuopio T, Collan Y (1996) Mitotic counts in breast cancer. The influence of training on performance. Pathol Res Pract 192: 1095-1099
35. Landis JR, Koch GG (1977) The measurement of observer agreement for categorial data. Biometrics 33: 159-174
36. Lee AKC, Loda M, Mackarem G, Bosari S, DeLellis RA, Heatley GJ, Hughes K (1996) Lymph node negative invasive breast carcinoma I centimeter or less in size (T1aN0M0): Clinicopathologic features and outcome. Cancer 76: 761-771
37. MacGrogan G, Bonichon F, de Mascarel I, Trojani M, Durand M, Avril A (1995) Prognostic value of p 53 in breast invasive ductal carcinoma: An immunohistochemical study on 942 cases. Breast Cancer Res Treat 26: 71-81
38. Masters JRW, Camplejohn RS, Millis RR, Rubens RD (1987) Histological grade, elastosis, DNA ploidy and the response to chemotherapy of breast cancer. Br J Cancer 55: 455-457
39. Merkle DE, Winchester DJ, Goldsmith RA, August CZ, Wruck DM, Rademaker AW (1993) DNA flow cytometry and pathologic grading as prognostic guides in axillary node-negative breast cancer. Cancer 72: 1926-1932
40. Page DL, Jensen RA, Simpson JF (1998) Routinely available indicators of prognosis in breast cancer. Breast Cancer Res Treat 51: 195-208
41. Parl FF, Dupont WD (1982) A retrospective cohort study of histologic risk factors in breast cancer patients. Cancer 50: 2410-2416
42. Patey DH, Scarff RW (1928) The position of histology in the prognosis of carcinoma of the breast. Lancet 1: 801-804
43. Quenel N, Wafflart J, Bonichon F, de Mascarel I, Trojani M, Durnad M (1995) The prognostic value of c-erbB-2 in primary breast carcinomas: A study on 942 cases. Breast Cancer Res Treat 36: 283-291
44. Ravdin PM, Clark GM, Hilsenbeck SG, Owens MA, Vendely P, Pandian MR, McGuire WL (1992) A demonstration that breast cancer recurrence can be predicted by neural network analysis. Breast Cancer Res Treat 21: 47-53
45. Ravdin PM, Clark GM (1992) A practical application of neural network analysis for predicting outcome of individual breast cancer patients. Breast Cancer Res Treat 22: 285-293
46. Roberti NE (1997) The role of histologic grading in the prognosis of patients with carcinoma of the breast. Cancer 80: 1708-1716
47. Rosner D, Lane WE (1990) Node negative minimal invasive breast cancer patients are not candidates for routine systemic adjuvant treatment. Cancer 66: 199-205
48. Royal College of Pathologists Working Group (1991) Pathology reporting in breast cancer screening. J Clin Pathol 44: 710-725
49. Saarikoski S (1986) Naistentautien Perustiedot. pp 62. Vammaspaino: Vammala
50. Silcocks P (1992) Some issues in observer error studies in pathology. J Pathol 168: 255-256
51. Simpson JF, Page DL (1994) Status of breast cancer prognostication based on histopathologic data. Am J Clin Pathol 102(Suppl): S3-S8
52. Stierer M, Rosen HR, Weber B, Marczell A, Komek GV, Czerwenka E (1992) Long term analysis of factors influencing the outcome in carcinoma of the breast smaller than 1 centimeter. Surg Gynecol Obstet 175: 151-159
53. Theissig F, Kunze KD, Haroske G, Meyer W (19901 Histological grading of breast cancer. Interobserver reproducibility and prognostic significance. Path Res Pract 186: 732-736
54. Van Diest PJ, Baak JPA (1991)The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients. Hum Pathol 22: 326-330
55. WHO (1981) Histological typing of breast tumours. In International Histological Classification of Tumours. Geneva: World Health Organization
56. Wulff HR (1981) Pålideligheten af deskriptive data. In Rationel Klinik, Grundlaget for Diagnostiske og Terapeutiske Beslutninger. pp 48-54. Copenhagen: Munksgaard